First Horizon Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-189
Closed -$35K 2485
2021
Q2
$35K Hold
189
﹤0.01% 919
2021
Q1
$29K Hold
189
﹤0.01% 950
2020
Q4
$30K Buy
189
+21
+13% +$3.33K ﹤0.01% 774
2020
Q3
$19K Hold
168
﹤0.01% 838
2020
Q2
$19K Hold
168
﹤0.01% 829
2020
Q1
$15K Sell
168
-202
-55% -$18K ﹤0.01% 845
2019
Q4
$40K Sell
370
-1,250
-77% -$135K ﹤0.01% 630
2019
Q3
$158K Sell
1,620
-2,070
-56% -$202K 0.01% 357
2019
Q2
$482K Hold
3,690
0.04% 227
2019
Q1
$499K Buy
3,690
+275
+8% +$37.2K 0.04% 221
2018
Q4
$332K Sell
3,415
-63
-2% -$6.13K 0.03% 261
2018
Q3
$482K Hold
3,478
0.04% 245
2018
Q2
$431K Buy
3,478
+3,415
+5,421% +$423K 0.04% 260
2018
Q1
$6K Sell
63
-152
-71% -$14.5K ﹤0.01% 1178
2017
Q4
$26K Sell
215
-143
-40% -$17.3K ﹤0.01% 730
2017
Q3
$50K Buy
358
+15
+4% +$2.1K 0.01% 498
2017
Q2
$42K Buy
343
+74
+28% +$9.06K ﹤0.01% 535
2017
Q1
$33K Sell
269
-9
-3% -$1.1K ﹤0.01% 662
2016
Q4
$34K Hold
278
﹤0.01% 645
2016
Q3
$34K Sell
278
-28
-9% -$3.42K ﹤0.01% 639
2016
Q2
$35K Hold
306
﹤0.01% 608
2016
Q1
$43K Sell
306
-13
-4% -$1.83K ﹤0.01% 578
2015
Q4
$61K Sell
319
-18
-5% -$3.44K 0.01% 446
2015
Q3
$52K Sell
337
-5
-1% -$772 0.01% 515
2015
Q2
$61K Buy
342
+55
+19% +$9.81K 0.01% 490
2015
Q1
$50K Sell
287
-53
-16% -$9.23K 0.01% 555
2014
Q4
$63K Sell
340
-4
-1% -$741 0.01% 481
2014
Q3
$57K Buy
344
+14
+4% +$2.32K 0.01% 500
2014
Q2
$51K Buy
330
+58
+21% +$8.96K 0.01% 544
2014
Q1
$41K Sell
272
-41
-13% -$6.18K 0.01% 567
2013
Q4
$43K Buy
313
+231
+282% +$31.7K 0.01% 516
2013
Q3
$10K Hold
82
﹤0.01% 829
2013
Q2
$8K Buy
+82
New +$8K ﹤0.01% 582